Intellia Therapeutics
Price & Volume
Stats
See more52W Range | $12.82-$34.87 |
Market Cap | $1.4B |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $43M |
Revenue Growth (YoY) | -24% |
Gross Profit (12 Mos) | -$367.8M |
Diluted EPS | -$5.45 |
News
See moreYahoo Finance • last month
Intellia Therapeutics, Inc. (NTLA) the Most Promising Biotech Stock According to Hedge Funds?
Yahoo Finance • 2 months ago
2 Cathie Wood Stocks That Could Soar 32% and 282%, According to Wall Street
Yahoo Finance • 3 months ago
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
About
CEO | Dr. John M. Leonard M.D. |
Address | 40 Erie Street, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 526 |
